Sequence information
Variant position: 162 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 372 The length of the canonical sequence.
Location on the sequence:
PSRARLELRFAAAAAAAPEG
G WELSVAQAGQGAGADPGPVL
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human PSRARLELRFAAAAAAAPEGG WELSVAQAGQGAGADPGPVL
Mouse PTRARLELRLEAESEDT--GG WELSVALWADA--EHPGPEL
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
Propeptide
30 – 253
Literature citations
Loss-of-function mutations in growth differentiation factor-1 (GDF1) are associated with congenital heart defects in humans.
Karkera J.D.; Lee J.S.; Roessler E.; Banerjee-Basu S.; Ouspenskaia M.V.; Mez J.; Goldmuntz E.; Bowers P.; Towbin J.; Belmont J.W.; Baxevanis A.D.; Schier A.F.; Muenke M.;
Am. J. Hum. Genet. 81:987-994(2007)
Cited for: INVOLVEMENT IN CHTD6; VARIANTS CHTD6 227-CYS--ARG-372 DEL AND THR-318; VARIANTS TOF ASP-162; PRO-309 AND THR-312; VARIANT CTHM TYR-267; VARIANTS HIS-68 AND SER-262;
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.